| Financial Year |
March 31 2023 |
| Monetary Funds |
228,761,095.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,150,000.00 |
| Accounts Receivable |
128,738,834.77 |
| Advances to Suppliers |
50,793,880.47 |
| Other Receivables |
99,103,404.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
52,417,033.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,519,400.00 |
| Other Current Assets |
11,157,265.62 |
| Total Current Assets |
640,539,964.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
79,698,108.62 |
| Long-term Equity Investment |
456,706,853.32 |
| Investment Properties |
4,120,363.62 |
| Fixed Assetes |
2,297,728,482.62 |
| Under-construction Projects |
272,235,532.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
207,133,360.11 |
| R&D expenses |
-- |
| Goodwill |
6,799,980.00 |
| Long-Term Deferred and Prepaid Expenses |
42,214,614.66 |
| Deferred Income Tax Assets |
25,529,346.29 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,495,612,380.26 |
| Total Assets |
4,136,152,344.92 |
| Short-Term Loans |
325,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
153,768,478.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
115,628,709.42 |
| Taxes Payable |
61,400,470.32 |
| Interest Payable |
-- |
| Dividend Payable |
1,304,487.73 |
| Other payables |
70,983,642.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,517,291.86 |
| Other Current Liabilities |
33,556,430.01 |
| Sub-Total of Current Liabilities |
1,124,434,029.52 |
| Long-term Loans |
628,090,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
299,548,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
158,086.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
994,660,244.52 |
| Total Liabilities |
2,119,094,274.04 |
| Paid-In Capital(Or Share Stock) |
538,400,659.00 |
| Capital Surplus |
1,397,581,241.35 |
| Surplus Reserve |
98,190,892.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-253,704,988.90 |
| Minority Stockholder's Interest |
234,948,965.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,782,109,105.61 |
| Owner's Equity（Stockholder's Equity） |
2,017,058,070.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,136,152,344.92 |
